Chair(s)
Lectures of the session
08:30
Maximizing safety for facial injectable procedures: arterial wall penetration forces of needles versus cannulas
08:50
Purity as a key differentiator for Xeomin vs. conventional BoNT-A formulations
09:30
08:30
Maximizing safety for facial injectable procedures: arterial wall penetration forces of needles versus cannulas
08:50
Purity as a key differentiator for Xeomin vs. conventional BoNT-A formulations
09:30